• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[个体化心血管预防:何时以及应进行到何种程度?]

[Individualized cardiovascular prevention: when and how far should it go?].

作者信息

Guize L

机构信息

Service de Cardiologie A, Hôpital Broussais, Paris.

出版信息

Ann Cardiol Angeiol (Paris). 1998 Nov;47(9):617-25.

PMID:9864557
Abstract

Individualised cardiovascular prevention must primarily be applied to patients with coronary heart disease or another obvious atherosclerotic disease and to apparently healthy subjects, but presenting a high risk (which implies the detection of these subjects) and their close relatives. The European recommendations for the prevention of coronary heart disease in clinical practice have been recently up-dated. Calculation of the multifactorial absolute risk (probability of developing an event over a given period, taking into account all modifiable and non-modifiable risk factors) represents a decisional aid to intervene on lifestyle and drug prescription. However, the available tables and software require certain adjustments. Diet is a major determinant of the cardiovascular risk and has one of the most important, but most complex impacts on prevention. Restriction of saturated fats, a Mediterranean type of diet and caloric restriction in the case of obesity are the main objectives. Smoking cessation is essential. For all these measures, a specialist referral is too frequently neglected. Aerobic physical activity is recommended. Hypertension must be controlled regardless of age. The objective is to obtain blood pressure figures less than 140/90 mmHg, and even lower in the case of diabetes or renal disease. Evidence of the benefit of controlling hypercholesterolaemia has been reinforced and the objectives to be achieved have been redefined: in secondary prevention and in high-risk subjects, the target total cholesterol must be less than 1.90 g/l and LDL cholesterol must be less than 1.15 g/l. The control of all risk factors must be reinforced in diabetic patients and fasting blood glucose must be maintained between 0.91 and 1.20 g/l in insulin-dependent diabetic patients with coronary heart disease.

摘要

个体化心血管预防主要应适用于冠心病或其他明显动脉粥样硬化疾病患者以及看似健康但存在高风险(这意味着要检测出这些个体)的人群及其近亲。欧洲关于临床实践中冠心病预防的建议最近已更新。计算多因素绝对风险(考虑所有可改变和不可改变风险因素,在给定时间段内发生事件的概率)有助于在生活方式干预和药物处方方面做出决策。然而,现有的表格和软件需要进行某些调整。饮食是心血管风险的主要决定因素之一,对预防有着最重要但也是最复杂的影响。限制饱和脂肪摄入、采用地中海式饮食以及对肥胖者进行热量限制是主要目标。戒烟至关重要。对于所有这些措施,专科转诊常常被忽视。建议进行有氧运动。无论年龄大小,高血压都必须得到控制。目标是使血压值低于140/90 mmHg,对于糖尿病或肾病患者,血压目标值甚至更低。控制高胆固醇血症益处的证据得到了加强,并且重新定义了要达到的目标:在二级预防和高风险人群中,目标总胆固醇必须低于1.90 g/l,低密度脂蛋白胆固醇必须低于1.15 g/l。糖尿病患者必须加强对所有风险因素的控制,对于患有冠心病的胰岛素依赖型糖尿病患者,空腹血糖必须维持在0.91至1.20 g/l之间。

相似文献

1
[Individualized cardiovascular prevention: when and how far should it go?].[个体化心血管预防:何时以及应进行到何种程度?]
Ann Cardiol Angeiol (Paris). 1998 Nov;47(9):617-25.
2
[Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].[2000年西班牙的胆固醇血症控制。心血管疾病预防工具。卫生与消费部、西班牙心脏病学会和西班牙动脉硬化学会]
Rev Esp Salud Publica. 2000 May-Jun;74(3):215-53.
3
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
4
[Cardiovascular risk factors and prevention in women: similarities and differences].[女性心血管危险因素与预防:异同]
Ital Heart J Suppl. 2001 Feb;2(2):125-41.
5
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].[慢性肾脏病(CKD)患者的动脉高血压和血脂异常。抗血小板聚集。目标导向治疗]
Nefrologia. 2008;28 Suppl 3:39-48.
6
European and American recommendations for coronary heart disease prevention.欧美冠心病预防建议。
Eur Heart J. 1998 Feb;19 Suppl A:A12-9.
7
[What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].大型临床试验让我们了解到关于2型糖尿病合并高血压患者心血管和肾脏预防的哪些信息?
Nephrol Ther. 2006 May;2(2):51-74. doi: 10.1016/j.nephro.2006.01.004. Epub 2006 Mar 9.
8
[Prevalence and management of major risk factors in 500 men with stable coronary disease].
Ann Cardiol Angeiol (Paris). 1998 Oct;47(8):543-8.
9
[Recommendations for the control of cholesterolemia in Spain].[西班牙胆固醇血症控制建议]
Rev Esp Salud Publica. 2000 Sep-Dec;74(5-6):457-74.
10
Secondary prevention of coronary heart disease in elderly patients.老年患者冠心病的二级预防
Am Fam Physician. 2005 Jun 15;71(12):2289-96.